173 results on '"Rajasegaran, Vikneswari"'
Search Results
2. NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
3. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing
4. Morphologic and genetic heterogeneity in breast fibroepithelial lesions—a comprehensive mapping study
5. Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
6. Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors.
7. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours
8. Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
9. An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours
10. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions
11. Supplementary Figures 1-6 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
12. Data from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
13. Supplementary Table 5 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
14. Supplementary Methods and Supplementary Figure and Table Legends from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
15. Supplementary Table 4 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
16. Supplementary Table 2 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
17. Supplementary Table 1 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
18. Supplementary Table 4 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
19. Supplementary Table 3 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
20. Supplementary Table 3 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
21. Supplementary Table 1 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
22. Supplementary Figure 1 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
23. Data from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
24. Supplementary Table 2 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
25. Data from Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel β-Catenin/TCF Target Gene
26. Supplementary Information, Figures 1-10 from Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel β-Catenin/TCF Target Gene
27. Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
28. A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples
29. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR–CCNB3 gene fusion
30. Elephant Shark Sequence Reveals Unique Insights into the Evolutionary History of Vertebrate Genes: A Comparative Analysis of the Protocadherin Cluster
31. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases
32. Enhancement of Mitochondrial Membrane Potential and Pro-Survival Pathways with Azole Compound C7 Resulting in Expansion of Hematopoietic Stem and Progenitor Cells
33. Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors
34. Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
35. PCAF interacts with XBP-1S and mediates XBP-1S-dependent transcription
36. Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes
37. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma
38. Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma
39. Sequencing and comparative analysis of fugu protocadherin clusters reveal diversity of protocadherin genes among teleosts
40. Recurrent PD-L1 Structural Rearrangements in Natural Killer/T Cell Lymphoma Patients with Complete Response to PD-1 Blockade Therapy
41. Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes.
42. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours
43. Molecular insights into paediatric breast fibroepithelial tumours
44. Clear cell sarcomas of the kidney are characterised byBCORgene abnormalities, including exon 15 internal tandem duplications andBCOR-CCNB3gene fusion
45. The draft genome of tropical fruit durian (Durio zibethinus)
46. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
47. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
48. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression
49. Genomic landscapes of breast fibroepithelial tumors
50. Whole‐exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.